HT
AGRX

HAP Trading’s Agile Therapeutics AGRX Stock Holding History

HAP Trading’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9
Closed -$1K – 2975
2021
Q3 		$1K Sell
9
-34
-79% -$77K ﹤0.01% 2375
2021
Q2 		$6K Sell
43
-7
-14% -$23.1K ﹤0.01% 2123
2021
Q1 		$19K Buy
50
+20
+67% +$108K ﹤0.01% 1488
2020
Q4 		$14K Buy
30
+3
+11% +$17.7K ﹤0.01% 1831
2020
Q3 		$27K Buy
27
+19
+238% +$109K ﹤0.01% 1110
2020
Q2 		$8K Hold
8
– – ﹤0.01% 1493
2020
Q1 		$3K Buy
+8
New +$45.9K ﹤0.01% 1134

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return